Literature DB >> 29457218

Regulatory T cells are required for normal and activin-promoted wound repair in mice.

Eric Haertel1, Natasha Joshi1, Paul Hiebert1, Manfred Kopf1, Sabine Werner1.   

Abstract

Healing of skin wounds is orchestrated by various types of immune cells, but little is known about the role of FoxP3+ regulatory T cells (Tregs) in this process. Here, we determined if Tregs are important for wound healing in normal mice and if they contribute to the accelerated healing of mice overexpressing the growth and differentiation factor activin. Diphtheria toxin induced Treg depletion prior to injury caused impaired healing characterized by delayed reepithelialization, reduced wound contraction, and impaired vessel maturation. The accelerated wound repair of activin-transgenic mice was also abrogated. Mechanistically, we found a strong increase in IL-4 levels combined with overrepresentation of T-bet+ and GATA-3+ αβ T cells in Treg-depleted 7-day wounds. In addition, numbers of IFN-γ- or IL-17A-producing CD4+ and CD4- T cells were elevated. These results demonstrate that Treg depletion in wounds facilitates the expansion of an αβ T-cell population with features of Th1 and Th2 cells, and suggest that concomitant changes in the cytokine milieu disturb the healing process.
© 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Activin; Cytokine; Inflammation; Treg; Wound healing

Mesh:

Substances:

Year:  2018        PMID: 29457218     DOI: 10.1002/eji.201747395

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  17 in total

1.  Staphylococcus aureus impairs cutaneous wound healing by activating the expression of a gap junction protein, connexin-43 in keratinocytes.

Authors:  Wei Xu; Elodi Dielubanza; Amanda Maisel; Kai Leung; Thomas Mustoe; Seok Hong; Robert Galiano
Journal:  Cell Mol Life Sci       Date:  2020-05-14       Impact factor: 9.261

2.  Degradable Hydrogels for the Delivery of Immune-modulatory Proteins in the Wound Environment.

Authors:  Margarete Johnson; Jessica Lloyd; Srinivas Tekkam; Stephen N Crooke; Deborah A Witherden; Wendy L Havran; M G Finn
Journal:  ACS Appl Bio Mater       Date:  2020-07-18

Review 3.  Stem cell dynamics, migration and plasticity during wound healing.

Authors:  Sophie Dekoninck; Cédric Blanpain
Journal:  Nat Cell Biol       Date:  2019-01-02       Impact factor: 28.824

4.  Activin-mediated alterations of the fibroblast transcriptome and matrisome control the biomechanical properties of skin wounds.

Authors:  Mateusz S Wietecha; Marco Pensalfini; Michael Cangkrama; Bettina Müller; Juyoung Jin; Jürgen Brinckmann; Edoardo Mazza; Sabine Werner
Journal:  Nat Commun       Date:  2020-05-25       Impact factor: 14.919

Review 5.  Immune Cell Therapies to Improve Regeneration and Revascularization of Non-Healing Wounds.

Authors:  Elena Groppa; Andrea Colliva; Roman Vuerich; Tea Kocijan; Serena Zacchigna
Journal:  Int J Mol Sci       Date:  2020-07-23       Impact factor: 5.923

6.  T Lymphocytes Attenuate Dermal Scarring by Regulating Inflammation, Neovascularization, and Extracellular Matrix Remodeling.

Authors:  Xinyi Wang; Swathi Balaji; Emily H Steen; Hui Li; Meredith M Rae; Alexander J Blum; Qi Miao; Manish J Butte; Paul L Bollyky; Sundeep G Keswani
Journal:  Adv Wound Care (New Rochelle)       Date:  2019-10-16       Impact factor: 4.730

Review 7.  Harnessing regulatory T cell neuroprotective activities for treatment of neurodegenerative disorders.

Authors:  Jatin Machhi; Bhavesh D Kevadiya; Ijaz Khan Muhammad; Jonathan Herskovitz; Katherine E Olson; R Lee Mosley; Howard E Gendelman
Journal:  Mol Neurodegener       Date:  2020-06-05       Impact factor: 14.195

8.  Prevascularization of dermal substitutes with adipose tissue-derived microvascular fragments enhances early skin grafting.

Authors:  Florian S Frueh; Thomas Später; Christina Körbel; Claudia Scheuer; Anna C Simson; Nicole Lindenblatt; Pietro Giovanoli; Michael D Menger; Matthias W Laschke
Journal:  Sci Rep       Date:  2018-07-20       Impact factor: 4.379

9.  Use of Tregs as a cell-based therapy via CD39 for benign prostate hyperplasia with inflammation.

Authors:  Xi Jin; Tianhai Lin; Guang Yang; Huawei Cai; Bo Tang; Xinyang Liao; Huifang Li; Xiaoting Chen; Lina Gong; Hang Xu; Yi Sun; Ping Tan; Jianqiong Yin; Hongwen Ma; Jianzhong Ai; Kunjie Wang; Qiang Wei; Lu Yang; Hong Li
Journal:  J Cell Mol Med       Date:  2020-03-19       Impact factor: 5.310

10.  The immunologic changes during different phases of intestinal anastomotic healing.

Authors:  Feng Zhang; Song Qiao; Chunqiao Li; Bo Wu; Stefan Reischl; Philipp-Alexander Neumann
Journal:  J Clin Lab Anal       Date:  2020-07-21       Impact factor: 2.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.